Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T May

Showing results (741-750 of 817) with videos related to

Pageof 82
Sort By:
Circulation. Cardiovascular Quality and Outcomes|November 15, 2012
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studiesLu Wang, Yiqing Song, Joann E Manson, et al.
JAMA|November 18, 2014
Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trialJoseph B Muhlestein, Donald L Lappé, Joao A C Lima, et al.
Iscience|July 8, 2020
A Genetic Analysis of Tumor Progression in Drosophila Identifies the Cohesin Complex as a Suppressor of Individual and Collective Cell InvasionBrenda Canales Coutiño, Zoe E Cornhill, Africa Couto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2016
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisAndrea J Low, Gitau Mburu, Nicky J Welton, et al.
JACC. Cardiovascular Imaging|December 19, 2021
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility TrialJoseph B Muhlestein, Kirk U Knowlton, Viet T Le, et al.
Journal of Medicinal Chemistry|May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor AgonistsGirdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
American Heart Journal|April 21, 2009
Superior predictive ability for death of a basic metabolic profile risk scoreHeidi T May, Benjamin D Horne, Brianna S Ronnow, et al.
The American Journal of Medicine|June 3, 2009
Exceptional mortality prediction by risk scores from common laboratory testsBenjamin D Horne, Heidi T May, Joseph B Muhlestein, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
Pageof 82

Showing results (741-750 of 817) with videos related to

Sort By:
Pageof 82
Circulation. Cardiovascular Quality and Outcomes|November 15, 2012
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studiesLu Wang, Yiqing Song, Joann E Manson, et al.
JAMA|November 18, 2014
Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trialJoseph B Muhlestein, Donald L Lappé, Joao A C Lima, et al.
Iscience|July 8, 2020
A Genetic Analysis of Tumor Progression in Drosophila Identifies the Cohesin Complex as a Suppressor of Individual and Collective Cell InvasionBrenda Canales Coutiño, Zoe E Cornhill, Africa Couto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2016
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisAndrea J Low, Gitau Mburu, Nicky J Welton, et al.
JACC. Cardiovascular Imaging|December 19, 2021
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility TrialJoseph B Muhlestein, Kirk U Knowlton, Viet T Le, et al.
Journal of Medicinal Chemistry|May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor AgonistsGirdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
American Heart Journal|April 21, 2009
Superior predictive ability for death of a basic metabolic profile risk scoreHeidi T May, Benjamin D Horne, Brianna S Ronnow, et al.
The American Journal of Medicine|June 3, 2009
Exceptional mortality prediction by risk scores from common laboratory testsBenjamin D Horne, Heidi T May, Joseph B Muhlestein, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
Pageof 82